{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-103023","form_type":"8-K","ticker":"BMEA","cik":"0001840439","company_name":"Biomea Fusion, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.288752+00:00","generated_at":"2026-05-17T20:59:36.324409+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Biomea Fusion Q2 net loss narrows to $20.7M, raises $42.8M, pipeline advances","bullets":["Net loss $20.7M (Q2 2025) vs $37.3M (Q2 2024); R&D expenses halved to $16.6M.","Raised ~$42.8M gross from public offering; cash runway extended into H2 2026.","Icovamenib at ADA 2025: durable HbA1c reduction, enhanced beta-cell function; combo with semaglutide showed superior glycemic control and weight loss with lean mass preservation.","BMF-650 achieved up to 15% weight loss in obese monkeys; IND submission on track for H2 2025.","Workforce reduced; quarterly expenses expected ~40% lower; oncology program BMF-500 ended, seeking partnerships."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-103023","json":"https://secwatch.observer/filing/0000950170-25-103023.json","markdown":"https://secwatch.observer/filing/0000950170-25-103023.md","text":"https://secwatch.observer/filing/0000950170-25-103023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840439/000095017025103023/0000950170-25-103023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840439/000095017025103023/bmea-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:59:36.324409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}